Nutritional Strategies To Improve VRE Control

Enrico Morello,Sara Roversi,Giulia Brambilla,Liana Signorini,Marianna Lorenzoni,Marco Andreoli,Simona Bernardi,Michele Malagola,Mirko Farina,Vera Radici,Gabriele Magliano,Simona Fiorentini,Arnaldo Caruso,Domenico Russo

DOI: https://doi.org/10.1016/j.jtct.2024.03.007

Abstract:The rise of Vancomycin-resistant enterococci (VRE) strains among cellular therapy recipients raises concerns due to increased morbidity, mortality, and hospitalization costs, particularly impacting transplanted patients with diminished survival expectations. Recent research linking lactose to Enterococcus growth and graft-versus-host disease (GVHD) emphasizes the need for data on reducing lactose in the diets of VRE-carrying patients, especially in cellular therapy contexts like CAR-T or allogeneic hematopoietic stem cell transplantation. Responding to elevated VRE positivity rates in rectal swabs among patients in our BMT Unit, a unique nutritional strategy was implemented, introducing lactose-free milk and strictly enforcing lactose-free diets. This approach resulted in a significant reduction in VRE carriers, with a 16% positivity rate in the Lactose Group versus 3.6% in the Lactose-Free Group, as of June 2023. These results indicate the potential efficacy of this innovative nutritional strategy in high-risk departments, such as BMT Units and Intensive Care Units, with implications for reducing isolation strategies and inappropriate antibiotic use in cases of VRE colonization.